Astaxanthin | Prediabetes Supplements Research

astaxanthin diabetes diet supplement and metabolic syndrome managementAstaxanthin supplement science abstracts related to diabetes and pre-diabetes metabolic syndrome.

Go to PubMed and copy the title in the search field.

An intervention study in obese mice with astaxanthin, a marine carotenoid – effects on insulin signaling and pro-inflammatory cytokines.

Astaxanthin inhibits thrombosis in cerebral vessels of stroke-prone spontaneously hypertensive rats.

Effect of astaxanthin on cycling time trial performance.

Positive Effects of Astaxanthin on Lipid Profiles and Oxidative Stress in Overweight Subjects.

Plasma carotenoid concentrations before and after supplementation with astaxanthin in middle-aged and senior subjects.

Marine carotenoids and cardiovascular risk markers.

Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease.

Ameliorative effect of astaxanthin on endothelial dysfunction in streptozotocin-induced diabetes in male rats.

Carotenoids in marine animals.

Astaxanthin: a potential therapeutic agent in cardiovascular disease.

Effects of Astaxanthin on Oxidative Stress in Overweight and Obese Adults.

High dose astaxanthin lowers blood pressure and increases insulin sensitivity in rats: are these effects interdependent?

Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes.

Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae.

Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro.

ROS production in neutrophils from alloxan-induced diabetic rats treated in vivo with astaxanthin.

Astaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive rats.

Astaxanthin ameliorates the redox imbalance in lymphocytes of experimental diabetic rats.

Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia.

Astaxanthin, oxidative stress, inflammation and cardiovascular disease.

Inhibitory effect of astraxanthin combined with Flavangenol on oxidative stress biomarkers in streptozotocin-induced diabetic rats.

Astaxanthin, a carotenoid with potential in human health and nutrition.

Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model.

Astaxanthin addition improves human neutrophils function: in vitro study.

Astaxanthin prevents in vitro auto-oxidative injury in human lymphocytes.

Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans.

Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia.

Carotenoids and cardiovascular disease.

Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophages.

Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress.

Function of marine carotenoids.

Inhibitory effect of astraxanthin combined with Flavangenol on oxidative stress biomarkers in streptozotocin-induced diabetic rats.

Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.

Biologic activity of carotenoids related to distinct membrane physicochemical interactions.

Astaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive rats.

Effect of astaxanthin supplementation on inflammation and cardiac function in BALB/c mice.

Share Button